Sadik Al-Hassan MP: speeches
Sadik Al-Hassan MP: full overview
4 Jul 2024–3 Jul 2025
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Parliamentary contributions: dates and coverage
- Source checked
- 19 Nov 2026
- Last successful import
- 19 Nov 2026
- Records dated through
- 18 Nov 2026
- Selected period
- Reporting year 1: 4 Jul 2024 to 3 Jul 2025
- Completeness
- Published snapshot: 20,988 records in the source window 21 Aug 2026 to 19 Nov 2026. The published snapshot covers its stated source window. Older imports can extend beyond it; not every public speech is included.
This page lists the parliamentary spoken contributions we hold for Sadik Al-Hassan in the reporting year 1 (4 Jul 2024 to 3 Jul 2025). It does not include every public speech, party-conference address or constituency event. Latest retained contribution in this period: 17 Jun 2025. The source check date and dataset limits are shown above. Open the Hansard link for the full debate and surrounding context.
Read what this MP said, asked and contributed in Parliament.
20 published records · newest first.
Speeches
- 17 Jun 2025 · Medicine Supply Chain: Community Pharmacies · Hansard source
More
3. If he will undertake a review of the potential impact of medicine supply chain shortages on community pharmacies.
- 17 Jun 2025 · Medicine Supply Chain: Community Pharmacies · Hansard source
More
Having worked in community pharmacies for nearly 20 years, I have witnessed at first hand the pain that medicine shortages can cause North Somerset patients and their loved ones. Will the Minister meet me, along with my hon. Friend the Member for Exeter (Steve Race) and other members of the all-party parliamentary group on pharmacy, to discuss the outcome of our inquiry into these shortages?
- 13 Jun 2025 · Terminally Ill Adults (End of Life) Bill · Read the full contribution in Hansard
More
Before entering this place last July as the Member for North Somerset, I had been a pharmacist for nearly 20 years. Pharmacists have a unique role in our healthcare system as the group of health professionals who specialise in drug usage and safety. That is where I wish to focus my thoughts today, and on which I offer the House my expertise.
- 13 Jun 2025 · Terminally Ill Adults (End of Life) Bill · Hansard source
More
Will the hon. Gentleman give way?
- 13 Jun 2025 · Terminally Ill Adults (End of Life) Bill · Hansard source
More
I would like to share my expertise as a pharmacist with the hon. Member. Drugs can be used for many indications and are quite commonly used in unlicensed situations, where there would be less evidence to support them than in the situation that we are discussing today with new clause 13: an idea that is incredibly well researched, practised and evidenced in multiple countries.
- 13 Jun 2025 · Terminally Ill Adults (End of Life) Bill · Hansard source
More
As a pharmacist, I should say that the drugs to be used for assisted dying are commonly used in pharmacy now. It would be obvious for pharmacies to supply those drugs in some way, shape or form. I accept the hon. Member’s point about medicines being used, but he will, I hope, accept my point: how would the same studies used to approve treatments be used to approve their use for death?
- 13 Jun 2025 · Terminally Ill Adults (End of Life) Bill · Hansard source
More
Will the hon. Lady give way?
- 2 Jun 2025 · Draft Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 · Read the full contribution in Hansard
More
I start by reminding the Committee again about my entry in the Register of Members’ Financial Interests, which includes a number of pharmacy-related entries as a registered pharmacist, including my employment by PillTime prior to being elected to the House. With that out of the way, may I say how genuinely thrilled I am to be here this evening?
- 2 Jun 2025 · Draft Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 · Read the full contribution in Hansard
More
It is a pleasure to serve under your chairship, Mr Stuart. I refer hon. Members to my entry in the Register of Members’ Financial Interests as a registered pharmacist, and previously a superintendent pharmacist of a distance-selling pharmacy. Although it is great to hear the hon.
- 19 May 2025 · Support for Veterans · Hansard source
More
The rights of the charity PTSD Resolution—which provided vital healthcare services in our stretched NHS—to deliver services that imprisoned veterans desperately need have been taken away in England. Will the Secretary of State meet me to discuss how the MOD and other signatories to the armed forces covenant can support the case of veteran prisoners, and to explain why precious support from a charity has been taken away?
- 14 May 2025 · Animal Welfare (Import of Dogs, Cats and Ferrets) Bill · Hansard source
More
I thank the hon. Gentleman, the Minister and all those involved for bringing this legislation to close those loopholes. I have two cats myself, Cookie and Sprinkles, so I thank the hon. Gentleman for his private Member’s Bill that will allow a safe practice for people to have pets, which will rightfully help their mental health. I am sure that the hon. Gentleman agrees that the Bill is vital and much needed.
- 23 Jan 2025 · Tobacco and Vapes Bill (Eleventh sitting) · Read the full contribution in Hansard
More
It is a pleasure to serve under your chairmanship, Sir Roger. Current medicine regulations do not allow products to be advertised, but do not get in the way of smoking cessation clinics that currently take place at GP surgeries or pharmacies. The amendments the hon. Lady is proposing are, therefore, not needed. In fact, as my hon.
- 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Read the full contribution in Hansard
More
Q We have spoken a bit about the gradual change and about that preventing uptake, but how does the gradual change in the age of sale affect the impact on tobacco and vaping behaviour, compared with increasing the age of sale in one go? That is based on comments we have heard about the difficulty in asking people’s ages at 34 or 35—I think most people have no problem knowing I am old enough for most things nowadays.
- 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Read the full contribution in Hansard
More
Q I thought you said that there are no licensed products on the market? Dr Laura Squire: There are not, which is why that is the way we would prefer to do it. Again, if we licensed these consumer products as a medicine, there are very strict requirements on labelling and on what needs to be given to the patient to explain what the product is and its risks. That is not there with these consumer cigarettes.
- 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Read the full contribution in Hansard
More
Q Thank you, Chair. In a couple of your answers it seemed that you were almost putting the point that maybe a vape should be a medicinal product. Is that the view of the MHRA? Dr Laura Squire: I do not have a view on whether a vape should be a medicinal product.
- 7 Jan 2025 · Tobacco and Vapes Bill (Second sitting) · Hansard source
More
Q When we give a new medicine to somebody, we give them advice and explain what it is and what it is safe to do with it. When people get vapes, do they get the right level of information and advice about what that product actually is and about the risks? Dr Laura Squire: They would do if it was a licensed product.
- 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Read the full contribution in Hansard
More
Q Do you think the introduction of a generational ban on smoking could cause an increase in the use of other nicotine products, such as vapes or smoke-free tobacco? Hazel Cheeseman: The purpose of the legislation is to reduce smoking. The Department’s projections in the impact assessment clearly show that, even on conservative estimates, it will achieve that goal over time. So the question then is, does that lead to displacement into other products?
- 7 Jan 2025 · Tobacco and Vapes Bill (First sitting) · Read the full contribution in Hansard
More
Q Thank you for the evidence submissions so far. In your opinion, will the Bill’s restriction of flavours for vaping products prevent the appeal to children and ex-smokers, if they can no longer access such products? Sir Francis Atherton: The issue of flavours and colours speaks to the issue of marketing towards children that we have been speaking about so far.
- 17 Dec 2024 · Community Pharmacies: Devon and the South-west · Read the full contribution in Hansard
More
It is a pleasure to serve under your chairship, Mr Betts. Over the past two decades I have had the privilege of working in a range of community pharmacies across the south-west and elsewhere. I thank the hon. Member for Tiverton and Minehead (Rachel Gilmour) for the best birthday present I could ask for: an opportunity to talk about a passion that has defined my life and that I am still proud to practice today.
- 4 Nov 2024 · Income Tax (Charge) · Read the full contribution in Hansard
More
Thank you, Madam Deputy Speaker. I congratulate hon. Friends who have made excellent and moving maiden speeches so far—they have set a high bar today and over the past few weeks—but we have, as they say, saved the best until almost last. I thank the people of North Somerset for the trust that they have placed in me. I promise them that I will not, for a moment, stop fighting to fulfil the promises that I have made to them.
Explore activity by topic or department
Contributions by debate topic
4 Jul 2024–3 Jul 2025. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →